Almitas Capital »

Acelrx Pharmaceuticals shares owned by Almitas Capital

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Almitas Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $349k 467k 0.75

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin SHS (FBTC)
Blackrock Mun Target Term Tr Com Shs Ben In (BTT)
Asa Gold And Precious Mtls L SHS (ASA)
Amylyx Pharmaceuticals (AMLX)
Design Therapeutics (DSGN)
Nuveen PA Investnt Quality Municipal (NQP)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Lyell Immunopharma Com New (LYEL)
Bio Rad Labs Cl A (BIO)
Cannae Holdings (CNNE)
Cornerstone Total Rtrn Fd In (CRF)
Blackrock Health Sciences Te Com Shs (BMEZ)
Alx Oncology Hldgs (ALXO)
Brightspire Capital Com Cl A (BRSP)
Bny Mellon Strategic Municipal Bond Fund closed end income funds non-taxable (DSM)

View all positions for Almitas Capital

Top funds holding Acelrx Pharmaceuticals

AIGH Capital Management
Rock Springs Capital Management
Nantahala Capital Management
Rosalind Advisors
Bleichroeder
Cantor Fitzgerald, L. P.
Empery Asset Management
Caption Management
Almitas Capital
Vanguard Capital Management
Dauntless Investment Group
Geode Capital Management
Shay Capital
Renaissance Technologies
Citadel Advisors

View all funds holding Acelrx Pharmaceuticals